Page last updated: 2024-11-02

pentamidine and Carcinoma, Lewis Lung

pentamidine has been researched along with Carcinoma, Lewis Lung in 1 studies

Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.

Carcinoma, Lewis Lung: A carcinoma discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. (From Cancer Chemother Rep 2 1972 Nov;(3)1:325) It is also called 3LL and LLC and is used as a transplantable malignancy.

Research Excerpts

ExcerptRelevanceReference
"The LD50 of pentamidine on cancer cells maintained in vitro is correlated with the endo-exonuclease enzyme activity."1.32The DNA double-stranded break repair protein endo-exonuclease as a therapeutic target for cancer. ( Alaoui-Jamali, MA; Chow, TY; Griller, D; Yeh, C; Yuen, L, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chow, TY1
Alaoui-Jamali, MA1
Yeh, C1
Yuen, L1
Griller, D1

Other Studies

1 other study available for pentamidine and Carcinoma, Lewis Lung

ArticleYear
The DNA double-stranded break repair protein endo-exonuclease as a therapeutic target for cancer.
    Molecular cancer therapeutics, 2004, Volume: 3, Issue:8

    Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic;

2004